Cargando…

Hyperglycemia in Acute Critically Ill COVID-19 Patients

Detalles Bibliográficos
Autores principales:	Cilloniz, Catia, Pericàs, Juan M., Motos, Anna, Gabarrús, Albert, Ferrer, Ricard, Menéndez, Rosario, Riera, Jordi, García-Gasulla, Dario, Peñuelas, Oscar, Fernández-Barat, Laia, Ángel Lorente, José, de Gonzalo-Calvo, David, Barbé, Ferran, Torres, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SEPAR. Published by Elsevier España, S.L.U. 2023
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461233/ https://www.ncbi.nlm.nih.gov/pubmed/36167740 http://dx.doi.org/10.1016/j.arbres.2022.09.001

Ejemplares similares

Risk factors associated with mortality among elderly patients with COVID-19: Data from 55 intensive care units in Spain
por: Cilloniz, C., et al.
Publicado: (2023)

Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
por: Motos, Anna, et al.
Publicado: (2022)

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
por: Cillóniz, Catia, et al.
Publicado: (2023)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

CIBERESUCICOVID: un proyecto estratégico para una mejor comprensión y manejo clínico de la COVID-19 en pacientes críticos
por: Torres, Antoni, et al.
Publicado: (2021)

Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort
por: González, Jessica, et al.
Publicado: (2021)

Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients
por: Molinero, Marta, et al.
Publicado: (2022)

Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS
por: García-Hidalgo, María C., et al.
Publicado: (2022)

One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients
por: González, Jessica, et al.
Publicado: (2022)

Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection()
por: García-Hidalgo, María C., et al.
Publicado: (2022)

Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection
por: Molinero, Marta, et al.
Publicado: (2022)

Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
por: García‐Hidalgo, María C., et al.
Publicado: (2022)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
por: Cillóniz, Catia, et al.
Publicado: (2020)

Evaluación de secuelas respiratorias en los pacientes con COVID-19, dónde estamos y hacia dónde vamos. Estudios CIBERESUCICOVID y RECOVID para comparar pacientes ingresados en UCI vs. sala convencional
por: Menéndez, Rosario, et al.
Publicado: (2022)

Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward
por: Menéndez, Rosario, et al.
Publicado: (2022)

Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study
por: González, Jessica, et al.
Publicado: (2022)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients
por: de GONZALO-CALVO, DAVID, et al.
Publicado: (2021)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2021)

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2012)

Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis
por: Pérez de Llano, Luis A., et al.
Publicado: (2022)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients With COVID-19- and Non-COVID-19-Induced Acute Respiratory Distress Syndrome
por: Barbeta, Enric, et al.
Publicado: (2022)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis
por: Cillóniz, Catia, et al.
Publicado: (2011)

Community-acquired pneumonia in critically ill very old patients: a growing problem
por: Cillóniz, Catia, et al.
Publicado: (2020)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Three to Six Months Evolution of Pulmonary Function and Radiological Features in Critical COVID-19 Patients: A Prospective Cohort
por: Cabo-Gambin, Ramón, et al.
Publicado: (2022)

SARS-CoV-2–induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas-Exchange Abnormalities
por: Barbeta, Enric, et al.
Publicado: (2020)

Characteristics and Outcomes in Patients with Ventilator-Associated Pneumonia Who Do or Do Not Develop Acute Respiratory Distress Syndrome. An Observational Study
por: Barbeta, Enric, et al.
Publicado: (2020)

One-year mortality after ICU admission due to COVID-19 infection
por: Ceccato, Adrian, et al.
Publicado: (2022)

Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation
por: González, Jessica, et al.
Publicado: (2023)

ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome
por: Martin-Loeches, Ignacio, et al.
Publicado: (2021)

Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
por: Fernández-Barat, Laia, et al.
Publicado: (2018)

Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Epidemiology, etiology, and risk factors of bacterial pneumonia
por: Torres, Antoni, et al.
Publicado: (2015)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0hrutlsi9gpnnm9glbcnq7mht4